Niagen Bioscience (NAGE) Inventory (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Inventory data on file, last reported at $24.0 million in Q1 2026.

• On a quarterly basis, Inventory rose 114.72% year-over-year to $24.0 million in Q1 2026; TTM through Mar 2026 was $24.0 million, a 114.72% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 122.19% from the prior year.
• Inventory for Q1 2026 stood at $24.0 million, up from $20.4 million in the prior quarter.
• Over the last five years, Inventory for NAGE reached as high as $24.0 million in Q1 2026 and fell as low as $9.2 million in Q4 2024.
• Historically, Inventory has averaged $14.4 million across 5 years, with a median of $14.4 million in 2025.
• Across the five-year window, Inventory tumbled 36.72% in 2024 and jumped 122.19% in 2025, its largest moves.
• Year by year, Inventory stood at $14.7 million in 2022, then decreased by 1.04% to $14.5 million in 2023, then tumbled by 36.72% to $9.2 million in 2024, then surged by 122.19% to $20.4 million in 2025, then gained by 17.59% to $24.0 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $24.0 million in Q1 2026, $20.4 million in Q4 2025, and $18.8 million in Q3 2025.